124 related articles for article (PubMed ID: 3139333)
1. Growth hormone response to growth hormone releasing factor in diabetic men.
Kopelman PG; Mason AC; Noonan K; Monson JP
Clin Endocrinol (Oxf); 1988 Jan; 28(1):33-8. PubMed ID: 3139333
[TBL] [Abstract][Full Text] [Related]
2. Effect of pyridostigmine on the growth hormone response to growth hormone-releasing hormone in lean and obese type II Diabetic patients.
Giustina A; Bresciani E; Tassi C; Girelli A; Valentini U
Metabolism; 1994 Jul; 43(7):893-8. PubMed ID: 8028515
[TBL] [Abstract][Full Text] [Related]
3. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.
Ismail IS; Scanlon MF; Peters JR
Clin Endocrinol (Oxf); 1993 Feb; 38(2):149-57. PubMed ID: 8094648
[TBL] [Abstract][Full Text] [Related]
4. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1988 Mar; 66(3):489-94. PubMed ID: 3127415
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin.
Tannenbaum GS; Lapointe M; Gurd W; Finkelstein JA
Endocrinology; 1990 Dec; 127(6):3087-95. PubMed ID: 1979030
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus.
Micić D; Macut D; Popović V; Kendereski A; Sumarac-Dumanović M; Zorić S; Dieguez C; Casanueva FF
Metabolism; 1999 Apr; 48(4):525-30. PubMed ID: 10206449
[TBL] [Abstract][Full Text] [Related]
7. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
Procopio M; Maccario M; Grottoli S; Oleandri SE; Boffano GM; Camanni F; Ghigo E
Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266
[TBL] [Abstract][Full Text] [Related]
8. Non-specific response of serum growth hormone to thyrotropin-releasing hormone in diabetics.
Pan CY; Lu JM; Chang XM; Luo GC; Li H
Chin Med J (Engl); 1989 Jan; 102(1):41-4. PubMed ID: 2504551
[TBL] [Abstract][Full Text] [Related]
9. Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity.
Kopelman PG; Noonan K; Goulton R; Forrest AJ
Clin Endocrinol (Oxf); 1985 Jul; 23(1):87-94. PubMed ID: 2863016
[TBL] [Abstract][Full Text] [Related]
10. Effect of dietary restriction and repeated growth hormone-releasing factor injections on growth hormone response to growth hormone-releasing factor in obese subjects.
Csizmadi I; Brazeau P; Serri O
Metabolism; 1989 Oct; 38(10):1016-21. PubMed ID: 2507875
[TBL] [Abstract][Full Text] [Related]
11. Effect of growth hormone releasing hormone on growth hormone, prostaglandin E2 and insulin in non-insulin-dependent diabetic patients.
Koev D; Zacharieva S; Popova J; Andonova K
Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):137-40. PubMed ID: 8740245
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
13. The response of obese subjects to continuous infusion of human pancreatic growth hormone-releasing factor 1-44.
Davies RR; Turner SJ; Cook D; Alberti KG; Johnston DG
Clin Endocrinol (Oxf); 1985 Nov; 23(5):521-5. PubMed ID: 3936648
[TBL] [Abstract][Full Text] [Related]
14. The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes.
Wurzburger MI; Prelevic GM; Sönksen PH; Balint-Peric LA; Wheeler M
J Clin Endocrinol Metab; 1993 Jul; 77(1):267-72. PubMed ID: 8325951
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone responses to growth-hormone-releasing hormone and thyrotropin-releasing hormone in diabetic patients with and without retinopathy.
Kaneko K; Komine S; Maeda T; Ohta M; Tsushima T; Shizume K
Diabetes; 1985 Jul; 34(7):710-3. PubMed ID: 3924695
[TBL] [Abstract][Full Text] [Related]
16. Fasting growth hormone levels in diabetes mellitus.
Nazaimoon WM; Ng ML; Khalid BA
Ann Acad Med Singap; 1993 Nov; 22(6):861-3. PubMed ID: 8129344
[TBL] [Abstract][Full Text] [Related]
17. Cholinergic blockade with pirenzepine induces dose-related reduction in glucose and insulin responses to a mixed meal in normal subjects and non-insulin dependent diabetics.
Bevan JS; Ara J; Page MD; Scanlon MF; Peters JR
Clin Endocrinol (Oxf); 1991 Jul; 35(1):85-91. PubMed ID: 1889143
[TBL] [Abstract][Full Text] [Related]
18. [The effect of synthetic human pancreatic growth hormone-releasing factor (hpGRF-44) on serum growth hormone response in normal and obese subjects].
Shimizu T; Inoue K
Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):82-96. PubMed ID: 3084310
[TBL] [Abstract][Full Text] [Related]
19. Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects.
Lanzi R; Luzi L; Caumo A; Andreotti AC; Manzoni MF; Malighetti ME; Sereni LP; Pontiroli AE
Metabolism; 1999 Sep; 48(9):1152-6. PubMed ID: 10484056
[TBL] [Abstract][Full Text] [Related]
20. Blunted growth hormone (GH) responsiveness to GH-releasing hormone in obese patients: influence of prolonged administration of the serotoninergic drug fenfluramine.
Argenio GF; Bernini GP; Sgró M; Vivaldi MS; Del Corso C; Santoni R; Franchi F
Metabolism; 1991 Jul; 40(7):724-7. PubMed ID: 1870427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
